Atherotech Diagnostics Lab Release: VAP Test Improves Identification of CIMT Progression

Published: Jan 26, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Expanded cholesterol assessment of moderate risk patients can play an important role in identifying and monitoring the progression of atherosclerosis. That’s according to a clinical study that used the VAP® (Vertical Auto Profile) Cholesterol Test to analyze lipids potentially associated with carotid intima-media thickness (CIMT).

Back to news